Veradermics

Veradermics is a late clinical-stage biopharmaceutical company founded by dermatologists with direct clinical experience in the treatment of pattern hair loss, a chronic condition that affects 50 million men and 30 million women in the US alone.

Our team combines dermatology expertise, clinical research leadership, and biotechnology innovation to advance new solutions and help bring clarity, evidence, and reliability to pattern hair loss.

Our mission: to set a new standard in pattern hair loss by developing treatments rooted in real evidence.

Our lead investigational product has the potential to be the first non-hormonal oral therapeutic for hair regrowth in men and women. Pattern hair loss is the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years.